FOR IMMEDIATE RELEASE:

Quincy Bioscience to Present at Minnesota Venture Capital Conference

MADISON, Wisconsin (January 17, 2005)

Quincy Bioscience has been chosen to give a presentation on the company, its products and technologies at the Minnesota Venture Capital 2005 Conference (www.mnvcc.com), to be held May 9-11 in Bloomington, MN. The company is seeking additional equity financing to further develop its therapeutic compound that addresses the imbalance of calcium ions related to the neuronal degeneration seen in diseases such as Alzheimer's, Parkinson's, Huntington's, Amyotrophic Lateral Sclerosis and other related diseases.

It is the goal of Quincy Bioscience to apply the technology developed from the aequorin molecule to develop products that fight the diseases of aging. Many different conditions are related to the disruption of calcium homeostasis and aequorin is being investigated to see how it may help restore the balance of that critical ion in the human body.

For more information, contact Mark Underwood at munderwood@quincybioscience.com or toll-free at 877-677-8652.